- Gum disease and tooth loss in postmenopausal women may be linked to a higher risk of death.
- The dental issues did not appear to increase the risk of cardiovascular disease. The findings suggest older women may benefit from more intensive oral screening measures.
Embargoed until 3 p.m. CT / 4 p.m. ET Wednesday, March 29, 2017
DALLAS, March 29, 2017 — Gum disease and tooth loss may be associated with a higher risk of death in postmenopausal women but not increased cardiovascular disease risk, according to new research in Journal of the American Heart Association, the Open Access Journal of the American Heart Association/American Stroke Association.
Loss of all natural teeth also was linked with an increased risk of death in postmenopausal women.
Periodontal disease, a chronic inflammatory disease of the gum and connective tissue surrounding the teeth, affects nearly two-thirds of U.S. adults 60 and older. The loss of all one’s teeth, called edentulism, impacts about one-third of U.S. adults 60 and older and often results from periodontal disease.
“Beside their negative impact on oral function and dietary habits, these conditions are also thought to be related to chronic diseases of aging,” said Michael J. LaMonte, Ph.D., M.P.H., study author and research associate professor in epidemiology and environmental health at the University at Buffalo in New York.
Researchers analyzed the health information from the Women’s Health Initiative program — a study of 57,001 women, 55 years and older.
“Previous studies included smaller sample sizes or had limited numbers of cardiovascular disease events for analysis. Ours is among the largest and focuses exclusively on postmenopausal women in whom periodontitis, total tooth loss and cardiovascular disease is high nationally,” LaMonte said.
In 6.7-year follow up of postmenopausal women studied, they found:
There were 3,589 cardiovascular disease events and 3,816 deaths.
History of periodontal disease was associated with a 12 percent higher risk of death from any cause.
Loss of all natural teeth was associated with a 17 percent higher risk of death from any cause. The risk of death associated with periodontal disease was comparable regardless of how often women saw their dentists.
Women who had lost their teeth were older, had more CVD risk factors, less education and visited the dentist less frequently compared to women with their teeth.
“Our findings suggest that older women may be at higher risk for death because of their periodontal condition and may benefit from more intensive oral screening measures,” LaMonte said. “However, studies of interventions aimed at improving periodontal health are needed to determine whether risk of death is lowered among those receiving the intervention compared to those who do not. Our study was not able to establish a direct cause and effect.”
Co-authors are Robert J. Genco, D.D.S., Ph.D.; Kathleen M. Hovey, M.S.; Robert B. Wallace, M.D., M.Sc.; Jo L. Freudenheim, Ph.D.; Dominique S. Michaud, Sc.D.; Xiaodan Mai, Ph.D.; Lesley F. Tinker, Ph.D.; Christian R. Salazar, Ph.D., M.P.H.; Christopher A. Andrews, Ph.D.; Wenjun Li, Ph.D.; Charles B. Eaton, M.D., M.S.; Lisa W. Martin, M.D.; and Jean Wactawski-Wende, Ph.D. Author disclosures are on the manuscript.
The National Heart, Lung, and Blood Institute supported the study.
- Dental photos are available on the right column of the release link http://newsroom.heart.org/news/gum-disease-tooth-loss-may-increase-postmenopausal-womens-risk-of-death?preview=fdbd40c9957a903dc413d5b26d90ac92
- After March 29, view the manuscript online.
- Recommendations for Heart Health
- Follow AHA/ASA news on Twitter @HeartNews
- For updates and new science from JAHA, follow @JAHA_AHA.
Statements and conclusions of study authors published in American Heart Association scientific journals are solely those of the study authors and do not necessarily reflect the association’s policy or position. The association makes no representation or guarantee as to their accuracy or reliability. The association receives funding primarily from individuals; foundations and corporations (including pharmaceutical, device manufacturers and other companies) also make donations and fund specific association programs and events. The association has strict policies to prevent these relationships from influencing the science content. Revenues from pharmaceutical and device corporations are available at www.heart.org/corporatefunding.
For Media Inquiries and AHA/ASA Spokesperson Perspective: (214) 706-1173
Karen Astle: (214) 706-1392; email@example.com
For Public Inquiries: (800)-AHA-USA1 (242-8721)
Life is why, science is how . . . we help people live longer, healthier lives.